News

The National Institutes of Health is offering up to $2 million in cash prizes to accelerate development of diagnostic and monitoring technologies to improve fetal health outcomes in low-resource settings.

NIH has awarded $24 million in first-year funding to establish Maternal Health Research Centers of Excellence. The centers will develop and evaluate innovative approaches to reduce pregnancy-related complications and deaths and promote maternal health equity.

A device known as a pessary, thought promising for reducing preterm birth risk due to a short cervix, appears no more effective than usual medical care, according to a study funded by the National Institutes of Health. A pessary is a rounded silicone device that fits around a cervix that has shortened, to keep it from opening and leading to miscarriage or preterm birth. The device is typically removed before the 37th week of pregnancy.

Depression from six weeks gestation through the end of pregnancy may increase the risk of heart and blood vessel disease up to two years after birth, suggests an analysis funded by the National Institutes of Health.

A new guide developed by NICHD and its partners promises to standardize the exchange of clinical data on maternal and infant health. The guide is an important step toward establishing a common framework to help clinicians and scientists better understand the root causes and high rates of maternal morbidity and mortality.

NIH has announced the next round of winners of its Connecting the Community for Maternal Health Challenge—a $3 million prize competition to encourage community-based and advocacy organizations in the United States to develop the infrastructure and capabilities necessary to conduct maternal health research.

Researchers have found the “Eat, Sleep, Console” (ESC) care approach to be more effective than using the Finnegan Neonatal Abstinence Scoring Tool (FNAST) to assess and manage opioid-exposed newborns, according to a national clinical trial funded by the National Institutes of Health.

Tranexamic acid appears no more effective than placebo in reducing the need for blood transfusion or preventing maternal death in patients with increased risk for excessive bleeding because of cesarean delivery, according to a study funded by the National Institutes of Health. Tranexamic acid slows the natural breakdown of blood clots and was considered promising for reducing the risk of excessive bleeding after giving birth—known as postpartum hemorrhage—after cesarean delivery.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has announced new funding for participating centers in its Maternal-Fetal Medicine Units (MFMU) Network.

The National Institutes of Health announced the next round of winners of its RADx® Tech for Maternal Health Challenge—an $8 million prize competition to accelerate development of technologies to improve maternal health outcomes.

The tool has the potential to assist with preterm birth, labor management and clinical decisionmaking.

NIH-funded technique enables automatic detection of placental compartments, oxygen status and structural abnormalities.

Computational analysis of the word usage in personal stories of recent birthing experiences can identify women likely to develop PTSD related to childbirth, suggests an NIH-funded study. The findings may aid development of a low-cost screening tool to help diagnose and treat childbirth-related PTSD.

Read about NICHD’s research findings and activities from 2022.

The Division of Intramural Research provides fundamental knowledge about the nature and behavior of living systems through basic, clinical, and population-based research.

The Pfizer-BioNTech and Moderna COVID-19 vaccines may offer slightly more protection during pregnancy against SARS-CoV-2, compared to the Jansen/Johnson & Johnson vaccine, suggests a study funded by the National Institutes of Health. Vaccination during the first and third trimesters appears to result in higher antibody-stimulated immune responses than vaccination in the second trimester. It also may lead to greater transfer of antibodies from maternal blood to the placenta.

Giving the hormone adiponectin to pregnant mice with obesity prevented later life obesity and related health conditions in their offspring, according to a study funded by the National Institutes of Health. The findings suggest that adiponectin, a hormone produced by fat cells, could play a role in reducing the lifelong obesity risk of children born to mothers with obesity during pregnancy.

Clinical research networks bring together scientists, clinicians, and community stakeholders to identify important clinical questions and design and conduct high-quality studies to answer them. Scientific evidence generated by such studies can impact clinical care, as several recent findings from NICHD’s networks demonstrate.

Vaccinating women against SARS-CoV-2 in mid to late pregnancy could provide their infants at least some protection against COVID-19 through six months of age, suggests a small study funded by the National Institutes of Health. Compared to infants born to mothers who had COVID-19 during pregnancy, infants born to vaccinated mothers were much more likely to have antibodies against the virus.

On average, scores on development tests were lower for infants born earlier in the range of a term pregnancy—from 37 to 41 weeks—than for those born later in the range, suggests a study by researchers at the National Institutes of Health. The slight difference in scores, first apparent at eight months, persisted through age seven. The findings may have implications for current practice guidelines recommending induction of labor for non-medical reasons at the 39th week of pregnancy.